GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 786 filers reported holding GLAXOSMITHKLINE PLC in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $252,000 | +24.8% | 5,704 | +7.8% | 0.04% | -45.7% |
| Q3 2021 | $202,000 | -49.5% | 5,289 | -47.4% | 0.08% | -18.2% |
| Q2 2021 | $400,000 | -0.2% | 10,049 | -10.6% | 0.10% | -5.7% |
| Q1 2021 | $401,000 | +15.9% | 11,240 | +19.5% | 0.10% | -14.6% |
| Q4 2020 | $346,000 | -9.7% | 9,404 | -7.6% | 0.12% | -15.8% |
| Q3 2020 | $383,000 | -9.9% | 10,177 | -2.4% | 0.15% | -19.8% |
| Q2 2020 | $425,000 | +3.9% | 10,422 | -3.4% | 0.18% | -15.7% |
| Q1 2020 | $409,000 | -78.0% | 10,793 | -72.7% | 0.22% | -70.1% |
| Q4 2019 | $1,856,000 | +4.3% | 39,490 | -5.3% | 0.72% | -10.0% |
| Q3 2019 | $1,779,000 | +6.8% | 41,685 | +0.1% | 0.80% | +5.9% |
| Q2 2019 | $1,666,000 | -16.5% | 41,639 | -12.8% | 0.76% | -14.7% |
| Q1 2019 | $1,995,000 | -1.8% | 47,728 | -10.2% | 0.89% | -13.4% |
| Q4 2018 | $2,031,000 | -8.3% | 53,147 | -3.6% | 1.02% | +8.9% |
| Q3 2018 | $2,216,000 | -3.7% | 55,154 | -3.4% | 0.94% | -9.4% |
| Q2 2018 | $2,302,000 | -5.0% | 57,102 | -7.9% | 1.04% | -4.2% |
| Q1 2018 | $2,424,000 | +24.1% | 62,032 | +12.6% | 1.08% | +45.9% |
| Q4 2017 | $1,953,000 | -9.1% | 55,074 | +4.1% | 0.74% | -18.7% |
| Q3 2017 | $2,149,000 | +1.8% | 52,927 | +8.1% | 0.91% | -1.6% |
| Q2 2017 | $2,111,000 | +18.8% | 48,950 | +16.1% | 0.93% | -7.1% |
| Q1 2017 | $1,777,000 | +61.0% | 42,156 | +47.0% | 1.00% | +48.1% |
| Q4 2016 | $1,104,000 | -5.9% | 28,673 | +5.4% | 0.68% | -17.4% |
| Q3 2016 | $1,173,000 | +2.6% | 27,199 | +3.1% | 0.82% | +28.3% |
| Q2 2016 | $1,143,000 | +4.8% | 26,379 | -2.0% | 0.64% | -9.0% |
| Q1 2016 | $1,091,000 | -1.4% | 26,916 | -1.8% | 0.70% | -2.1% |
| Q4 2015 | $1,106,000 | -5.3% | 27,399 | -9.8% | 0.72% | -8.9% |
| Q3 2015 | $1,168,000 | -7.5% | 30,382 | +0.2% | 0.78% | +3.0% |
| Q2 2015 | $1,263,000 | -15.8% | 30,313 | -6.7% | 0.76% | -14.0% |
| Q1 2015 | $1,500,000 | +8.5% | 32,497 | +0.4% | 0.89% | +7.0% |
| Q4 2014 | $1,383,000 | +8.4% | 32,356 | +16.5% | 0.83% | -1.5% |
| Q3 2014 | $1,276,000 | +169.2% | 27,765 | +213.1% | 0.84% | +164.5% |
| Q2 2014 | $474,000 | -3.3% | 8,867 | -3.3% | 0.32% | -7.6% |
| Q1 2014 | $490,000 | -19.1% | 9,167 | -19.2% | 0.34% | -19.4% |
| Q4 2013 | $606,000 | +16.1% | 11,352 | +9.2% | 0.43% | +5.2% |
| Q3 2013 | $522,000 | – | 10,400 | – | 0.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |